Quantoom Biosciences is a full‑stack RNA manufacturing partner dedicated to accelerating the development of mRNA and saRNA‑based vaccines and therapeutics. Their approach centers on the N‑Force toolbox, which combines three core technologies to transform any antigen into a high‑performance RNA‑LNP drug product: Ncode for sequence design and optimization, Ntensify® for construct‑agnostic RNA production, and Ncapsulate® for RNA‑LNP formulation.
With a mission to reinvent RNA technologies, Quantoom delivers solutions designed to reduce scale‑up risks, streamline workflows, and enhance reliability from early R&D through clinical and commercial manufacturing. Their integrated platforms provide scientists with a comprehensive, end‑to‑end solution that supports faster, more cost‑effective development of next‑generation RNA medicines.
Portfolio
Ncode – RNA Design Platform
Enables sequence design and optimization, turning antigen sequences into high‑performing mRNA or saRNA constructs.Ntensify® – RNA Production Platform
A construct‑agnostic, scalable RNA production system that integrates process design, reagent mixes, disposables, and equipment from R&D scale to commercial manufacturing.Ncapsulate® / Ncapsulate® QCX – RNA‑LNP Formulation Platform
Lipid nanoparticle (LNP) formulation technologies providing delivery chemistry and optimized processes for creating (sa)mRNA‑LNP drug products.Ntensify® mano – mRNA Production Kit
A ready‑to‑use, cost‑effective mRNA reagents kit containing all components needed for IVT and purification.Ntensify™ Midi – GMP‑Grade Production System
A GMP‑ready mRNA production platform designed for clinical and commercial batch manufacturing.Integrated Ntensify Process (IVT + Purification)
Standardized IVT & Purification Reagent Mixes
Scalable Production Equipment
Single‑Use Disposables
Sequence Design Services
Strategic R&D Partnerships & In‑Vitro / In‑Vivo De‑Risking Support
